九安醫療(002432.SZ):目前無法估算新冠抗原家用自測OTC試劑盒可能給公司帶來的業績變化
格隆匯11月25日丨九安醫療(002432.SZ)發佈股票交易風險提示公吿,公司子公司的新冠抗原家用自測OTC試劑盒在海外銷售收入和疫情的發展密切相關,因疫情發展的不可預見性、疫苗接種計劃的推進、產品應急使用授權(EUA)有效期,以及市場的發展和變化等多方面因素的影響,該產品獲得美國應急使用授權(EUA)後,公司目前尚無法預測未來由該產品給公司營業收入和業績帶來的影響,請投資者注意投資風險。
在互動易問答中,説明了“實際產能擴增進度和生產計劃將根據市場、訂單、及原材料供應等實際情況實時進行調整。”。產能為生產能力,無法由此推斷實際產量,更無法推斷出實際銷量。敬請投資者不要因概念混淆,出現錯誤推斷。
公司會嚴格執行上市公司信息披露相關規定,及時履行信息披露義務,也借此機會再次提醒投資者,美國疫情未來的發展情況尚具有較強的不確定性,公司的試劑盒產品銷售尚未滿一個月,目前無法估算該產品可能給公司帶來的業績變化,請廣大投資者注意投資風險,理性投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.